Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract.

Recs

0
Player Avatar Jamanji (< 20) Submitted: 6/16/2011 4:34:27 PM : Outperform Start Price: $35.46 SLXP Score: +39.49

Barron 6/15/11

Featured Broker Partners


Advertisement